Ghent University Academic Bibliography

Your filters: cql: author="Lanssens, Sven" or (type any "bookEditor issueEditor" and editor="Lanssens, Sven")

Add to list
- Journal Article
- A1
- open access
Dose reduction of IL17 and IL23 inhibitors in psoriasis (BeNeBio study) : an international, pragmatic, multicentre, randomised, controlled, non-inferiority trial

Juul M.P.A. van den Reek, Charlotte A.M. van Riel, Rani Soenen (UGent) , Anke Eylenbosch (UGent) , Lisa Schots, Lara S. van der Schoot, Lynda Grine, Gerjon Hannink, Fabienne Willaert, Tom Hillary, et al.

(2026) LANCET REGIONAL HEALTH-EUROPE. 67.
Add to list
- Journal Article
- A1
- open access
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management

Lynda Grine (UGent) , Michel de la Brassinne, Pierre‐Dominique Ghislain, Tom Hillary, Julien Lambert, Siegfried Segaert, Fabienne Willaert, Jo Lambert (UGent) , Farida Benhadou, Chantal Bonardeaux, et al.

(2020) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 34(4). p.676-684
Add to list
- Miscellaneous
- open access
In vivo derm dotting : an easy and inexpensive way for clinicopathological correlation

Sven Lanssens, Katrien Vossaert (UGent) and Sofie De Schepper (UGent)

(2019) DERMATOLOGY PRACTICAL & CONCEPTUAL. 9(1). p.71-72
Add to list
- Journal Article
- A1
- open access
Value of dermoscopy in a population-based screening sample by dermatologists

Isabelle Hoorens (UGent) , Katrien Vossaert (UGent) , Sven Lanssens, Laurence Dierckxsens, Giuseppe Argenziano and Lieve Brochez (UGent)

(2019) DERMATOLOGY PRACTICAL & CONCEPTUAL. 9(3). p.200-206
Add to list
- Conference Paper
- C3
Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Rani Soenen (UGent) , Evelyn Meulewaeter, Lynda Grine (UGent) , Linda Temmerman (UGent) , Sven Lanssens, Els Brouwers, Nathalie Van den Berghe, Reinhart Speeckaert (UGent) , Jo Lambert (UGent) and Ann Gils

(2019) 24th World Congress of Dermatology, Abstracts.
Add to list
- Journal Article
- A1
- open access
Clinical consequences of antibody formation, serum concentrations, and HLA-Cw6 status in psoriasis patients on Ustekinumab

Eline De Keyser, I Busard, Celine, Sven Lanssens, Lieve Meuleman, Barbara A. Hutten, Antonio Costanzo, Juul M. van den Reek, Jeffrey Zweegers, Jo Lambert (UGent) and I Spuls, Phyllis

(2019) THERAPEUTIC DRUG MONITORING. 41(5). p.634-639
Add to list
- Journal Article
- A1
- open access
Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy

Rani Soenen (UGent) , Evelyn Meulewaeter, Lynda Grine (UGent) , Nathalie Van den Berghe, Els Brouwers, Reinhart Speeckaert (UGent) , Sven Lanssens, Linda Temmerman, Jo Lambert (UGent) and Ann Gils

(2019) JOURNAL OF INVESTIGATIVE DERMATOLOGY. 139(10). p.2232-2235
Add to list
- Conference Paper
- C3
Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Rani Soenen (UGent) , Evelyn Meulewaeter, Lynda Grine (UGent) , Nathalie Van den Berghe, Els Brouwers, Reinhart Speeckaert (UGent) , Sven Lanssens, Linda Temmerman (UGent) , Jo Lambert (UGent) and Ann Gils

(2018) Skin Immune Mediated Inflammatory Diseases, 2nd European workshop, Abstracts.
Add to list
Incontinentia pigmenti

Katrien Vossaert (UGent) , Sven Lanssens, Emma Coussens, M Van den Kerckhove and Sofie De Schepper (UGent)

(2017) NEDERLANDS TIJDSCHRIFT VOOR DERMATOLOGIE & VENEREOLOGIE. 27(9). p.498-499
Add to list
Je bent jong en je wilt... een gave huid!

Emma Coussens, Sven Lanssens, Sofie De Schepper (UGent) , M Van Den Kerckhove and Katrien Vossaert (UGent)

(2017) NEDERLANDS TIJDSCHRIFT VOOR DERMATOLOGIE & VENEREOLOGIE. 27(9). p.483-485

Academic Bibliography

Dose reduction of IL17 and IL23 inhibitors in psoriasis (BeNeBio study) : an international, pragmatic, multicentre, randomised, controlled, non-inferiority trial

A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management

In vivo derm dotting : an easy and inexpensive way for clinicopathological correlation

Value of dermoscopy in a population-based screening sample by dermatologists

Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Clinical consequences of antibody formation, serum concentrations, and HLA-Cw6 status in psoriasis patients on Ustekinumab

Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy

Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Incontinentia pigmenti

Je bent jong en je wilt... een gave huid!

Contents

Support

Contact